Skip to content
Fervent PharmaFervent Pharma
Fervent Pharma
  • Home
  • Development
  • About Us
    • Our Mission
    • Our Leadership
    • News Archive
  • Contact
    • Phone: 252.558.9700
    • Info@FerventPharma.com
Search
FacebookLinkedin
  • Home
  • Development
  • About Us
    • Our Mission
    • Our Leadership
    • News Archive
  • Contact
    • Phone: 252.558.9700
    • Info@FerventPharma.com

News

Archive

Press Releases

Fervent Pharmaceuticals commences virtual at home Phase 2 Clinical Trial of a Peri- and Post-Menopausal Therapy for Treating Hot Flashes and Night Sweats

April 26, 2022
New Potential Treatment Option For Hot Flash Relief For Menopausal Women And Women Taking Tamoxifen®

March 18, 2019
Fervent Pharmaceuticals Completes Clinical Trial For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms

December 5, 2018
Fervent Pharmaceuticals Announces The Addition Of Ernest Mario, PhD to its Board Of Representatives

October 2, 2018
Clinical Trial Begins For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms

April 18, 2018
New Menopause Therapy from Fervent Pharmaceuticals to Begin Clinical Trial

January 2, 2018

News

How Changes in Weather May Effect Menopause Symptoms

February 7, 2019
Hot Flashes and Breast Cancer

February 1, 2019
Maintaining Bone Health

January 29, 2019
Hot Flashes Are A Frequent Side-Effect of Tamoxifen Therapy in Breast Cancer Treatment

January 24, 2019
The 7 Best Foods for Menopause

January 17, 2019
Staying Healthy at Menopause and Beyond

January 15, 2019
Contact Us

Info@FerventPharma.com

252.558.9700

740 Greenville Blvd. Suite 400–151
Greenville, NC 27858

    Copyright © 2022 Fervent Pharmaceuticals Inc. All Rights Reserved.

    Contact Us | Legal Disclaimer | Privacy Policy | |